Ajovy

Ajovy (Fremanezumab) is a prescription medication used for migraine prevention. This subcutaneous injection is designed to reduce the frequency of migraine episodes in eligible patients.

Ajovy is primarily used for the preventive treatment of migraines. It is administered via subcutaneous injection and is intended for adults who experience frequent migraine episodes. The medication works by targeting specific pathways involved in migraine pathogenesis, helping to reduce the number of migraine days per month. Patients should consult their healthcare provider to determine if Ajovy is suitable for their specific condition.

Common effects of Ajovy may include injection site reactions, such as redness, pain, or swelling. Some individuals may also experience fatigue, muscle pain, or flu-like symptoms. These effects are generally mild to moderate and may resolve on their own. Patients should report any persistent or severe side effects to their healthcare provider.

Ajovy should be used with caution in patients with a history of hypersensitivity to Fremanezumab or any of its components. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Ajovy may interact with other medications, including those that affect the immune system or blood clotting. Patients should avoid alcohol while using Ajovy, as it may increase the risk of side effects. It is crucial to discuss all current medications with a healthcare provider before starting Ajovy to ensure safety and effectiveness.